IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype-Reference-Cited by-同舟云学术

IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype

Published:2009-07-28 Issue:3 Volume:31 Page:342-349
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Suzuki Hiromu,Igarashi Shinichi,Nojima Masanori,Maruyama Reo,Yamamoto Eiichiro,Kai Masahiro,Akashi Hirofumi,Watanabe Yoshiyuki,Yamamoto Hiroyuki,Sasaki Yasushi,Itoh Fumio,Imai Kohzoh,Sugai Tamotsu,Shen Lanlan,Issa Jean-Pierre J.,Shinomura Yasuhisa,Tokino Takashi,Toyota Minoru

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/31/3/342/17287612/bgp179.pdf

Reference51 articles.

1. Lessons from hereditary colorectal cancer;Kinzler;Cell,1996

2. The epigenomics of cancer;Jones;Cell,2007

3. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state;Kanai;Carcinogenesis,2007

4. Aberrant methylations in cancer cells: where do they come from?;Ushijima;Cancer Sci.,2005

5. CpG island methylator phenotype in colorectal cancer;Toyota;Proc. Natl Acad. Sci. USA,1999

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct functions of wild-type and R273H mutant Δ133p53α differentially regulate glioblastoma aggressiveness and therapy-induced senescence;Cell Death & Disease;2024-06-27

2. IGFBP7 promotes gastric cancer by facilitating epithelial-mesenchymal transition of gastric cells;Heliyon;2024-05

3. Gastrointestinal Malignancy: Genetic Implications to Clinical Applications;Cancer Treatment and Research;2024

4. Differentially Expressed Genes Induced by Erythropoietin Receptor Overexpression in Rat Mammary Adenocarcinoma RAMA 37-28 Cells;International Journal of Molecular Sciences;2023-05-09

5. Epigenetic Alterations in Colorectal Cancer;Epigenetics and Human Health;2023